Live Breaking News & Updates on Junshi biosciences

Stay informed with the latest breaking news from Junshi biosciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Junshi biosciences and stay connected to the pulse of your community

Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital.

China , Xiamen , Fujian , Beijing , Yangzhou , Jiangsu , Decheng , Guangdong , Huadong , Chinese , Leiwen-chen , Junshi-biosciences

Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034

/PRNewswire/ -- DelveInsight's Giant-Cell Arteritis Market Insights report includes a comprehensive understanding of current treatment practices, giant-cell...

Italy , Shanghai , China , France , Spain , Taisho , Mie , Japan , United-kingdom , Germany , United-states , Oscotec-genosco

DelveInsight Business Research, LLP: Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034

DelveInsight Business Research, LLP: Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Germany , Italy , Spain , United-states , Taisho , Mie , Japan , France , United-kingdom , Oscotec-genosco

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Australia , Singapore , Maryland , United-states , Shanghai , China , Suzhou , Jiangsu , Peking , Beijing , Guangzhou , Guangdong

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

United-states , Beijing , China , Australia , Renji , Henan , Peking , Guangzhou , Guangdong , Shanghai , Singapore , San-francisco

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , United-states , San-francisco , California , Suzhou , Jiangsu , Australia , Shanghai , Maryland , Beijing

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

Ottawa , Ontario , Canada , Vietnam , Republic-of , Uruguay , Brunei , Laos , China , Shanghai , Brazil , Guangzhou

Junshi Biosciences Announces 2023 Full Year Financial

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Indonesia , Brunei , Panama , Beijing , China , Shanghai , New-zealand , India , Argentina , Guangzhou , Guangdong , Uruguay

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Argentina , New-zealand , Australia , Suzhou , Jiangsu , China , India , Beijing , Panama , San-francisco , California , United-states

China Medical System （867.HK）2023 Annual Results: Despite

China Medical System （867.HK）2023 Annual Results: Despite
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

China , Shenzhen , Guangdong , Singapore , Chinese , Junshi-biosciences , China-medical-system-holdings-ltd , National-volume-based-procurement-the , Rxilient-health , National-reimbursement-drug-list , China-medical-system , National-volume-based-procurement